Skip to search.
 STI Down0.49%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS

91.78 Down 0.61(0.66%) 03:19 SGT - Nasdaq Real Time Price

Add to Portfolio
Insider RosterGet Insider Roster for:
Insider Holders*
Individual/EntityMost Recent Trans.Shares Owned as of Trans. Date
BELL LEONARD
Officer
Automatic Sale
May 14, 2013
1,361,212
May 14, 2013
CARMICHAEL CLARE
Officer
Acquisition (Non Open Market)
Feb 6, 2013
10,700
Feb 6, 2013
COISSAC PATRICE
Officer
Sale
Oct 31, 2012
1,118
Oct 31, 2012
DUBIN THOMAS I H
Officer
Automatic Sale
Aug 23, 2012
65,705
Aug 23, 2012
HALLAL DAVID
Officer
Option Exercise
Jun 5, 2013
89,654
Jun 5, 2013
ISLAM SAQIB
Officer
Option Exercise
Apr 24, 2013
25,000
Apr 24, 2013
KELLER WILLIAM R
Director
Option Exercise
May 20, 2013
12,276
May 20, 2013
LINK MAX
Director
Acquisition (Non Open Market)
Feb 6, 2013
98,574
Feb 6, 2013
MACKAY MARTIN
Officer
Acquisition (Non Open Market)
May 13, 2013
25,000
May 13, 2013
MADRI JOSEPH A
Director
Acquisition (Non Open Market)
Feb 6, 2013
279,217
Feb 6, 2013
MATHIS LARRY
Director
Sale
Apr 29, 2013
29,456
Apr 29, 2013
MORIARTY JOHN B
Officer
Acquisition (Non Open Market)
Feb 6, 2013
17,200
Feb 6, 2013
NORBY R DOUGLAS
Director
Option Exercise
May 22, 2013
56,144
May 22, 2013
PARVEN ALVIN S
Director
Sale
Mar 8, 2013
7,311
Mar 8, 2013
RUMMELT ANDREAS
Director
Acquisition (Non Open Market)
Feb 6, 2013
12,786
Feb 6, 2013
SINHA VIKAS
Officer
Acquisition (Non Open Market)
Feb 6, 2013
312,655
Feb 6, 2013
SQUINTO STEPHEN P
Officer
Automatic Sale
Apr 29, 2013
108,462
Apr 29, 2013
VENEMAN ANN M
Director
Sale
Apr 29, 2013
5,918
Apr 29, 2013
WRIGHT FRANK J
Officer
Acquisition (Non Open Market)
Feb 6, 2013
14,700
Feb 6, 2013

View Transactions for Insiders & Institutional Holders

 
* Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.